AMS - 2021-HMca-Hospital Medicine- Cardiology (Downloadable)

$119.00

5 AMA PRA Category 1 Credits™
StreamingINCLUDED

Topics and Objectives

Title: HMca-Hospital Medicine- Cardiology-Valvular Heart Disease; Sudden Cardiac Death, Bradycardia and Atrioventricular Block; Diastolic Heart Failure and Hypertrophic Cardiomyopathy.

Faculty: Nicholas Ruggiero II, M.D. and Alyson N. Owen, M.D.

Original Release Date: July 1, 2021  Expiration Date: July 1, 2024

TOPIC 1: Valvular Heart Disease.

Upon completion of this session, the participant should be able to: GL, EBM, COMP

  1. Indicate when to order echocardiography for heart murmurs.
  2. Recognize the appropriate interval of repeat echocardiography imaging.
  3. Determine the timing of intervention for severe valvular heart disease as per the ACC/AHA Guidelines.
  4. Integrate the indications, strengths and weaknesses of Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter mitral valve repair.
  5. Discriminate the current and past indications for endocarditis prophylaxis as per the ACC/AHA Guidelines.

TOPIC 2: Sudden Cardiac Death, Bradycardia and Atrioventricular Block.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Determine which patients need additional evaluation and treatment of ventricular arrhythmias.
  2. Assess which patients need additional evaluation and treatment of cardiac conduction abnormalities as per ACC/AHA/HRS Guidelines.
  3. Recognize indications for permanent pacemakers.

TOPIC 3: Diastolic Heart Failure and Hypertrophic Cardiomyopathy.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Describe the prevalence and pathophysiology of diastolic heart failure.
  2. Identify effective treatment strategies for diastolic heart failure while considering Clinical Trials such as OPTIMIZE-HF, TOPCAT, PARAMOUNT, etc.
  3. Assess prognosis in patients with hypertrophic cardiomyopathy.
  4. Apply appropriate treatment strategies in patients with hypertrophic cardiomyopathy.


Total Cost: $

Title: HMca-Hospital Medicine- Cardiology-Valvular Heart Disease; Sudden Cardiac Death, Bradycardia and Atrioventricular Block; Diastolic Heart Failure and Hypertrophic Cardiomyopathy.

Faculty: Nicholas Ruggiero II, M.D. and Alyson N. Owen, M.D.

Original Release Date: July 1, 2021  Expiration Date: July 1, 2024

TOPIC 1: Valvular Heart Disease.

Upon completion of this session, the participant should be able to: GL, EBM, COMP

  1. Indicate when to order echocardiography for heart murmurs.
  2. Recognize the appropriate interval of repeat echocardiography imaging.
  3. Determine the timing of intervention for severe valvular heart disease as per the ACC/AHA Guidelines.
  4. Integrate the indications, strengths and weaknesses of Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter mitral valve repair.
  5. Discriminate the current and past indications for endocarditis prophylaxis as per the ACC/AHA Guidelines.

TOPIC 2: Sudden Cardiac Death, Bradycardia and Atrioventricular Block.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Determine which patients need additional evaluation and treatment of ventricular arrhythmias.
  2. Assess which patients need additional evaluation and treatment of cardiac conduction abnormalities as per ACC/AHA/HRS Guidelines.
  3. Recognize indications for permanent pacemakers.

TOPIC 3: Diastolic Heart Failure and Hypertrophic Cardiomyopathy.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Describe the prevalence and pathophysiology of diastolic heart failure.
  2. Identify effective treatment strategies for diastolic heart failure while considering Clinical Trials such as OPTIMIZE-HF, TOPCAT, PARAMOUNT, etc.
  3. Assess prognosis in patients with hypertrophic cardiomyopathy.
  4. Apply appropriate treatment strategies in patients with hypertrophic cardiomyopathy.